1-3 of 3
Roisin M. Connolly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B020: Dual checkpoint inhibition using anti-PD-1 and anti-CTLA-4 in combination with entinostat increases treatment efficacy and decreases suppressive signaling between myeloid cells and T cells in breast-to-lung metastasis

Edgar Gonzalez, Jesse Kreger, Yingtong Liu, Aaron Baugh, Julie Jang, Batul Al-Zubeidy, Ludmila Danilova, Sarah M Shin, Arianna Barbetta, Sara-Elisa B Bangerth, Matthew Jacobo, Sofi Castanon, Vered Stearns, Roisin M Connolly, Won Ho, Juliet Emaumaullee, Adam MacLean, Evanthia T Roussos-Torres
Journal: Cancer Immunology Research
Cancer Immunol Res (2025) 13 (2_Supplement): B020.
https://doi.org/10.1158/2326-6074.IO2025-B020
Published: 23 February 2025
View article titled, Abstract B020: Dual checkpoint inhibition using anti-PD-1 and anti-CTLA-4 in combination with entinostat increases treatment efficacy and decreases suppressive signaling between myeloid cells and T cells in breast-to-lung metastasis
Journal Articles

Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment

Dimitrios N. Sidiropoulos, Christine I. Rafie, Julie K. Jang, Sofi Castanon, Aaron G. Baugh, Edgar Gonzalez, Brian J. Christmas, Valerie H. Narumi, Emily F. Davis-Marcisak, Gaurav Sharma, Emma Bigelow, Ajay Vaghasia, Anuj Gupta, Alyza Skaist, Michael Considine, Sarah J. Wheelan, Sathish Kumar Ganesan, Min Yu, Srinivasan Yegnasubramanian, Vered Stearns, Roisin M. Connolly, Daria A. Gaykalova, Luciane T. Kagohara, Elizabeth M. Jaffee, Elana J. Fertig, Evanthia T. Roussos Torres
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (5): 656–669.
https://doi.org/10.1158/2326-6066.CIR-21-0170
Published: 03 May 2022
View article titled, Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2<sup>+</sup> Breast Tumor Microenvironment
Open the PDF for Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2<sup>+</sup> Breast Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs

Brian J. Christmas, Christine I. Rafie, Alexander C. Hopkins, Blake A. Scott, Hayley S. Ma, Kayla A. Cruz, Skylar Woolman, Todd D. Armstrong, Roisin M. Connolly, Nilo A. Azad, Elizabeth M. Jaffee, Evanthia T. Roussos Torres
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (12): 1561–1577.
https://doi.org/10.1158/2326-6066.CIR-18-0070
Published: 03 December 2018
View article titled, Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Open the PDF for Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs in another window
Includes: Supplementary data